13F-HR filed by Abingworth LLP
Abingworth LLP filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 16 holding rows worth $352,088,000 by the sum of the rows.
- Accession
- 0000950123-15-001866
- Filer
- CIK 1397144
- Filed
- 2015-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 13 entries on the cover page, a total value of $167,252,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $352,088,000 with VALUE read as thousands by filing date, 13F file number 028-14285. The quarter's positions are built on this report. The resolved quarter.
The cover page states a total of $167,252,000, 52% less than the sum of the rows, $352,088,000. This page uses the sum of the rows.
Other managers
- reports for this filerAbingworth Management LTD
- included managerAbingworth Management LTD
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ATRIUM THERAPEUTICS INC | N71546100 | COM | 6,213,924 | $116,511,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 1,301,413 | $49,974,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 2,199,012 | $36,877,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 930,682 | $26,357,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 2,879,328 | $23,927,000 | thousands by filing date | |
| LOMBARD MED INC | G55598109 | COM | 3,473,452 | $22,056,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 2,017,872 | $20,340,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 1,182,196 | $19,423,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 714,285 | $16,779,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 8,087,486 | $7,847,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 327,350 | $5,247,000 | thousands by filing date | |
| ZOGENIX INC | 98978L105 | COM | 2,335,218 | $3,176,000 | thousands by filing date | |
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 62,500 | $1,499,000 | thousands by filing date | |
| ONCOGENEX PHARMACEUTICALS IN | 68230A106 | COM | 603,740 | $1,352,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 437,994 | $679,000 | thousands by filing date | |
| ZALICUS INC | 98887C204 | COM | 7,896 | $44,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-15-001866 | this filing | 2015-02-13 | acceptance time not in the bulk data set |